AAAAAA
Results: 1-25/41
Authors:
Bard, JM
Charles, MA
Juhan-Vague, I
Vague, P
Andre, P
Safar, R
Fruchart, JC
Eschwege, E
Citation: Jm. Bard et al., Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity - The Biguanides and the Prevention of the Risk of Obesity (BIGPRO) 1 study, ART THROM V, 21(3), 2001, pp. 407-414
Authors:
Nalbone, G
Alessi, MC
Juhan-Vague, I
Citation: G. Nalbone et al., Fibrinolytic system, metalloproteinases and vascular diseases, M S-MED SCI, 17(2), 2001, pp. 170-176
Authors:
Tregouet, DA
Aubert, H
Henry, M
Morange, P
Visvikis, S
Juhan-Vague, I
Tiret, L
Citation: Da. Tregouet et al., Combined segregation-linkage analysis of plasma thrombin activatable fibrinolysis inhibitor (TAFI) antigen levels with TAR gene polymorphisms, HUM GENET, 109(2), 2001, pp. 191-197
Authors:
Ribba, AS
Loisel, I
Lavergne, JM
Juhan-Vague, I
Obert, B
Cherel, G
Meyer, D
Girma, JP
Citation: As. Ribba et al., Ser968Thr mutation within the A3 domain of von Willebrand Factor (VWF) in two related patients leads to a defective binding of VWF to collagen, THROMB HAEM, 86(3), 2001, pp. 848-854
Authors:
Morange, PE
Renucci, JF
Charles, MA
Aillaud, MF
Giraud, F
Grimaux, M
Juhan-Vague, I
Citation: Pe. Morange et al., Plasma levels of free and total TFPI, relationship with cardiovascular risk factors and endothelial cell markers, THROMB HAEM, 85(6), 2001, pp. 999-1003
Authors:
Lijnen, HR
Maquoi, E
Holvoet, P
Mertens, A
Lupu, F
Morange, P
Alessi, MC
Juhan-Vague, I
Citation: Hr. Lijnen et al., Adipose tissue expression of gelatinases in mouse models of obesity, THROMB HAEM, 85(6), 2001, pp. 1111-1116
Authors:
Sanmarco, M
Alessi, MC
Harle, JR
Sapin, C
Aillaud, MF
Gentile, S
Juhan-Vague, I
Weiller, PJ
Citation: M. Sanmarco et al., Antibodies to phosphatidylethanolamine as the only antiphospholipid antibodies found in patients with unexplained thromboses, THROMB HAEM, 85(5), 2001, pp. 800-805
Authors:
Lopez, S
Peiretti, F
Bonardo, B
Deprez-Beauclair, P
Laouenan, H
Juhan-Vague, I
Nalbone, G
Citation: S. Lopez et al., Effect of atorvastatin on plasminogen activator inhibitor type-1 synthesisin human monocytes/macrophages, J CARDIO PH, 37(6), 2001, pp. 762-768
Authors:
Scarabin, PY
Aillaud, MF
Luc, G
Lacroix, B
Mennen, L
Amouyel, P
Evans, A
Ferrieres, J
Arveiler, D
Juhan-Vague, I
Citation: Py. Scarabin et al., Haemostasis in relation to dietary fat as estimated by erythrocyte fatty acid composition: The prime study, THROMB RES, 102(4), 2001, pp. 285-293
Authors:
Peiretti, F
Lopez, S
Deprez-Beauclair, P
Bonardo, B
Juhan-Vague, I
Nalbone, G
Citation: F. Peiretti et al., Inhibition of p70(S6) kinase during transforming growth factor-beta 1/vitamin D-3-induced monocyte differentiation of HL-60 cells allows tumor necrosis factor-alpha to stimulate plasminogen activator inhibitor-1 synthesis, J BIOL CHEM, 276(34), 2001, pp. 32214-32219
Authors:
Marques-Vidal, P
Montaye, M
Haas, B
Bingham, A
Evans, A
Juhan-Vague, I
Ferrieres, J
Luc, G
Amouyel, P
Arveiler, D
Yarnell, J
Ruidavets, JB
Scarabin, PY
Ducimetiere, P
Citation: P. Marques-vidal et al., Relationships between alcoholic beverages and cardiovascular risk factor levels in middle-aged men, the PRIME study, ATHEROSCLER, 157(2), 2001, pp. 431-440
Authors:
Mavri, A
Alessi, MC
Bastelica, D
Geel-Georgelin, O
Fina, F
Sentocnik, JT
Stegnar, M
Juhan-Vague, I
Citation: A. Mavri et al., Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss, DIABETOLOG, 44(11), 2001, pp. 2025-2031
Authors:
Henry, M
Aubert, H
Morange, PE
Nanni, I
Alessi, MC
Tiret, L
Juhan-Vague, I
Citation: M. Henry et al., Identification of polymorphisms in the promoter and the 3 ' region of the TAFI gene: evidence that plasma TAFI antigen levels are strongly genetically controlled, BLOOD, 97(7), 2001, pp. 2053-2058
Authors:
Morange, PE
Henry, M
Brunet, D
Aillaud, MF
Juhan-Vague, I
Citation: Pe. Morange et al., Factor XIIIV34L is not an additional genetic risk factor for venous thrombosis in Factor V Leiden carriers, BLOOD, 97(6), 2001, pp. 1894-1895
Authors:
Ribba, AS
Hilbert, L
Lavergne, JM
Fressinaud, E
Boyer-Neumann, C
Ternisien, C
Juhan-Vague, I
Goudemand, J
Girma, JP
Mazurier, C
Meyer, D
Citation: As. Ribba et al., The arginine-552-cysteine (R1315C) mutation within the Al loop of von Willebrand factor induces an abnormal folding with a loss of function resultingin type 2A-like phenotype of von Willebrand disease: study of 10 patients and mutated recombinant von Willebrand factor, BLOOD, 97(4), 2001, pp. 952-959
Authors:
Charles, MA
Eschwege, E
Grandmottet, P
Isnard, F
Cohen, JM
Bensoussan, JL
Berche, H
Chapiro, O
Andre, P
Vague, P
Juhan-Vague, I
Bard, JM
Safar, M
Citation: Ma. Charles et al., Treatment with metformin of non-diabetic men with hypertension, hypertriglyceridaemia and central fat distribution: the BIGPRO 1.2 trial, DIABET M R, 16(1), 2000, pp. 2-7
Authors:
Juhan-Vague, I
Renucci, JF
Grimaux, M
Morange, PE
Gouvernet, J
Gourmelin, Y
Alessi, MC
Citation: I. Juhan-vague et al., Thrombin-activatable fibrinolysis inhibitor antigen levels and cardiovascular risk factors, ART THROM V, 20(9), 2000, pp. 2156-2161
Authors:
Morange, PE
Henry, M
Tregouet, D
Granel, B
Aillaud, MF
Alessi, MC
Juhan-Vague, I
Citation: Pe. Morange et al., The A-844G polymorphism in the PAI-1 gene is associated with a higher riskof venous thrombosis in factor V Leiden carriers, ART THROM V, 20(5), 2000, pp. 1387-1391
Authors:
Morange, PE
Lijnen, HR
Alessi, MC
Kopp, F
Collen, D
Juhan-Vague, I
Citation: Pe. Morange et al., Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity, ART THROM V, 20(4), 2000, pp. 1150-1154
Authors:
Marques-Vidal, P
Montaye, M
Haas, B
Bingham, A
Evans, A
Juhan-Vague, I
Ferrieres, J
Luc, G
Amouyel, P
Arveiler, D
McMaster, D
Ruidavets, JB
Bard, JM
Scarabin, PY
Ducimetiere, P
Citation: P. Marques-vidal et al., Association of hypertensive status and its drug treatment with lipid and haemostatic factors in middle-aged men: the PRIME Study, J HUM HYPER, 14(8), 2000, pp. 511-518
Authors:
Juhan-Vague, I
Alessi, MC
Morange, PE
Citation: I. Juhan-vague et al., Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity, ANN MED, 32, 2000, pp. 78-84
Authors:
Granel, B
Serratrice, J
Disdier, P
Pache, X
Weiller, PJ
Morange, P
Juhan-Vague, I
Citation: B. Granel et al., Acquired inhibitor of thrombin associated with an ulcerative colitis, AM J HEMAT, 64(4), 2000, pp. 322-322
Authors:
Chetaille, P
Alessi, MC
Kouassi, D
Morange, PE
Juhan-Vague, I
Citation: P. Chetaille et al., Plasma TAFI antigen variations in healthy subjects, THROMB HAEM, 83(6), 2000, pp. 902-905
Authors:
Robert, A
Aillaud, MF
Eschwege, V
Randrianjohany, A
Scarabin, Y
Juhan-Vague, I
Citation: A. Robert et al., ABO blood group and risk of venous thrombosis in heterozygous carriers of factor V leiden, THROMB HAEM, 83(4), 2000, pp. 630-631
Authors:
Canavy, I
Henry, M
Morange, PE
Tiret, L
Poirier, O
Ebagosti, A
Bory, M
Juhan-Vague, I
Citation: I. Canavy et al., Genetic polymorphisms and coronary artery disease in the south of France, THROMB HAEM, 83(2), 2000, pp. 212-216